Hepatocellular carcinoma (HCC) is the second leading cause of death due to cancer.
Although there are different treatment options, these strategies are not efficient in terms of …

Hepatocellular carcinoma (HCC), a primary malignancy of the liver, is a threat to the health
of all humans as a prevalent malignancy and is the sixth most common cancer worldwide. It …

Liver cancer is a severe concern for public health officials since the clinical cases are
increasing each year, with an estimated 5-year survival rate of 30%–35% after diagnosis …

Background Spiropachysine A is the extracted compound of traditional Chinese ethnic
medicine Pachysandra axillaries Franch. var. styiosa (Dunn) M. Cheng. Spiropachysine A is …

Lung cancer is listed as the most common reason for cancer-related death all over the world
despite diagnostic improvements and the development of chemotherapy and targeted …

Simple Summary The liver is the world's sixth most common primary tumor site, accountable
for nearly 5% of all cancers and over 8% of cancer-related deaths. Hepatocellular carcinoma …

Abstract Seleno-ovalbumin (Se-OVA) was a selenium conjugating protein synthesized by
the combination of ovalbumin (OVA) and inorganic selenium. In this paper, the structure of …

Aim: Hepatocellular carcinoma (HCC) is the world's second leading cause of cancerrelated
mortality and the fifth most prevalent cancer overall. Several synthetic and plant-based …

Systemic therapy options nowadays for advanced hepatocellular carcinoma (HCC) are
either immunotherapy with immune checkpoint inhibitors or targeted therapy. As the …

Background and Objectives: To evaluate the effectiveness of hepatic arterial infusion
chemotherapy (HAIC) followed by lipiodol infusion in advanced hepatocellular carcinoma …